Up to now, somatic inactivating mutations of the tumor suppressor gene TP53 and activating mutations of the proto-oncogene β-catenin (CTNNB1) were the most frequent mutations identified in ACC (13, 42, 45, 46). Here, TP53 is linked to adrenal cortex carcinoma.